NCT00285818View on ClinicalTrials.gov

Mifepristone Treatment for Patients With Non-psychotic Major Depressive Disorder Receiving Bilateral ECT

NACompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

January 31, 2009

Study Completion Date

April 30, 2009

Conditions
Depression
Interventions
DRUG

Mifepristone

Mifepristone is a glucocorticoid receptor antagonist.

DRUG

Placebo Oral Capsule

Placebo is a capsule without a pharmacological active ingredient

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT00285818 - Mifepristone Treatment for Patients With Non-psychotic Major Depressive Disorder Receiving Bilateral ECT | Biotech Hunter | Biotech Hunter